🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase II/III trial studies how well pazopanib, when combine...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2014-08-12
Trial ID
NCT02180867
This is a study of TRC105 in combination with standard dose pazopanib compa...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2017-02-13
Trial ID
NCT02979899
The Phase I part of the study will identify the doses of pazopanib and pacl...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07-09
Trial ID
NCT00866528
Treatments Being Tested
The main purpose of this study is to determine whether the combination of p...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07
Trial ID
NCT00871403
Treatments Being Tested
The aim of this research is to evaluate the potential interest of an associ...
Status
Completed
Location
Centre François BACLESSE
Start Date
2010-06
Trial ID
NCT01165385
The first part of this study is to find the recommended dosages of a combin...
Status
Terminated
Location
Royal United Hospital Bath NHS Trust
Start Date
2014-09
Trial ID
NCT02055690
Treatments Being Tested
This phase I trial studies the side effects and best dose of pazopanib hydr...
Status
Completed
Location
Washington University School of Medicine
Start Date
2013-05-31
Trial ID
NCT01716416
This is an open-label, multicenter dose-escalation phase I study using a 3+...
Status
Completed
Location
Centre Léon BERARD
Start Date
2010-07
Trial ID
NCT01202032
Treatments Being Tested
The goal of this study is to build on the experience of the SAINT trial by ...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-06-12
Trial ID
NCT07444619
Treatments Being Tested
This randomized phase II trial studies how well pazopanib hydrochloride wit...
Status
Terminated
Location
Illinois CancerCare-Peoria
Start Date
2018-02-16
Trial ID
NCT03334409
Treatments Being Tested